160
Views
39
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Treatment of refractory blistering autoimmune diseases with mycophenolic acid

, &
Pages 370-376 | Received 19 Jun 2006, Accepted 22 Jun 2006, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Jenny Sung Won Yun, Tami Yap, Raymond Martyres, Johannes S. Kern, George Varigos & Laura Scardamaglia. (2020) The association of mycophenolate mofetil and human herpes virus infection. Journal of Dermatological Treatment 31:1, pages 46-55.
Read now
Spyridoula Doukaki, Andrea Platamone, Roberta Alaimo & Maria Rita Bongiorno. (2015) Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus. Journal of Dermatological Treatment 26:1, pages 67-72.
Read now
Hakan M Gürcan & A Razzaque Ahmed. (2011) Current concepts in the treatment of epidermolysis bullosa acquisita. Expert Opinion on Pharmacotherapy 12:8, pages 1259-1268.
Read now
Spyridoula Doukaki, Giuseppe Pistone, Mario Aricò & Maria Rita Bongiorno. (2011) Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus. Expert Opinion on Drug Metabolism & Toxicology 7:2, pages 237-244.
Read now
Pamela Vezzoli, Emilio Berti & Angelo V Marzano. (2008) Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus. Expert Review of Clinical Immunology 4:3, pages 351-363.
Read now
Angelo V. Marzano, Stefano Ramoni, Diana Spinelli, Elvio Alessi & Emilio Berti. (2008) Refractory linear IgA bullous dermatosis successfully treated with mycophenolate sodium. Journal of Dermatological Treatment 19:6, pages 364-367.
Read now

Articles from other publishers (33)

Vishal Ahuja, Arvind Kumar Bhatt, Vaishali Sharma, Ranju Kumari Rathour, Nidhi Rana, Ravi Kant Bhatia, Sunita Varjani, Manu Kumar, Sara Magdouli, Yung-HunYang & Shashi Kant Bhatia. (2021) Advances in glucosamine production from waste biomass and microbial fermentation technology and its applications. Biomass Conversion and Biorefinery.
Crossref
Cai You, Fengwei Li, Xingwang Zhang, Li Ma, Yu‐Zhong Zhang, Wei Zhang & Shengying Li. (2021) Structural basis for substrate specificity of the peroxisomal acyl‐CoA hydrolase MpaH’ involved in mycophenolic acid biosynthesis. The FEBS Journal 288:19, pages 5768-5780.
Crossref
Meital Oren-Shabtai, Noa Kremer, Moshe Lapidoth, Eran Sharon, Lihi Atzmony, Adi Nosrati, Emmilia Hodak, Daniel Mimouni & Assi Levi. (2020) Treatment of Bullous Pemphigoid in People Aged 80 Years and Older: A Systematic Review of the Literature. Drugs & Aging 38:2, pages 125-136.
Crossref
Hideyuki Ujiie, Hiroaki Iwata, Jun Yamagami, Takekuni Nakama, Yumi Aoyama, Shigaku Ikeda, Norito Ishii, Keiji Iwatsuki, Michiko Kurosawa, Daisuke Sawamura, Akiko Tanikawa, Daisuke Tsuruta, Wataru Nishie, Wataru Fujimoto, Masayuki Amagai & Hiroshi Shimizu. (2019) Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita). The Journal of Dermatology 46:12, pages 1102-1135.
Crossref
Xiwei Chen, Lu Wang, Jinmei Zhang, Tao Jiang, Changhua Hu, Dehai Li & Yi Zou. (2019) Immunosuppressant mycophenolic acid biosynthesis employs a new globin-like enzyme for prenyl side chain cleavage. Acta Pharmaceutica Sinica B 9:6, pages 1253-1258.
Crossref
Lorena M. C. Costa, Mark A. Cappel & James H. Keeling. (2019) Clinical, pathologic, and immunologic features of pemphigus herpetiformis: a literature review and proposed diagnostic criteria. International Journal of Dermatology 58:9, pages 997-1007.
Crossref
Wei ZhangLei DuZepeng QuXingwang ZhangFengwei LiZhong LiFeifei QiXiao WangYuanyuan JiangPing MenJingran SunShaona CaoCe GengFengxia QiXiaobo WanChangning LiuShengying Li. (2019) Compartmentalized biosynthesis of mycophenolic acid. Proceedings of the National Academy of Sciences 116:27, pages 13305-13310.
Crossref
Sue-Ching Yeoh, Hong Hua, Juan Fernando Yepes & Douglas E. Peterson. 2019. Contemporary Oral Medicine. Contemporary Oral Medicine 1523 1639 .
Sue-Ching Yeoh, Hong Hua, Juan Fernando Yepes & Douglas E. Peterson. 2018. Contemporary Oral Medicine. Contemporary Oral Medicine 1 117 .
Valerie Laniosz, Julia S. Lehman, Gregory A. Poland & David A. Wetter. (2016) Literature-based immunization recommendations for patients requiring immunosuppressive medications for autoimmune bullous dermatoses. International Journal of Dermatology 55:6, pages 599-607.
Crossref
Naveed Sami. (2015) Mycophenolate mofetil (MMF) in the treatment of epidermolysis bullosa acquisita (EBA) long-term follow-up. JAAD Case Reports 1:5, pages 321-323.
Crossref
Catherine Prost-Squarcioni & Frédéric Caux. 2015. Blistering Diseases. Blistering Diseases 579 587 .
Mae N. Ramirez-Quizon, Luca Borradori, Russell P. HallIIIIII & Dédée F. Murrell. 2015. Blistering Diseases. Blistering Diseases 543 550 .
Marina Eskin-Schwartz & Daniel Mimouni. 2015. Blistering Diseases. Blistering Diseases 483 491 .
P.J. Keith, D.A. Wetter, J.W. Wilson & J.S. Lehman. (2014) Evidence-based guidelines for laboratory screening for infectious diseases before initiation of systemic immunosuppressive agents in patients with autoimmune bullous dermatoses. British Journal of Dermatology 171:6, pages 1307-1317.
Crossref
S. Koo, L.S. Gagne, P. Lee, P.P. Pratibhu, L.M. James, M.M. Givertz & F.M. Marty. (2014) Incidence and risk factors for herpes zoster following heart transplantation. Transplant Infectious Disease 16:1, pages 17-25.
Crossref
EA Georgakopoulou & C Scully. (2013) Systemic use of non-biologics in orofacial diseases: 2. Purine synthesis inhibitors. Oral Diseases, pages n/a-n/a.
Crossref
Andrea Baratta, Diana Camarillo, Christine Papa, James R. Treat, Aimee S. Payne, Suzanne S. Rozenber & Albert C. Yan. (2013) Pediatric Pemphigus Vulgaris: Durable Treatment Responses Achieved with Prednisone and Mycophenolate Mofetil (MMF). Pediatric Dermatology 30:2, pages 240-244.
Crossref
Masanao SAKANOUE, Kazuhiro KAWAI & Takuro KANEKURA. (2011) Bullous pemphigoid associated with type 1 diabetes mellitus responsive to mycophenolate mofetil. The Journal of Dermatology 39:10, pages 884-885.
Crossref
A.R. Ahmed & H.M. Gürcan. (2012) Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up. Journal of the European Academy of Dermatology and Venereology 26:9, pages 1074-1083.
Crossref
Marina Eskin-Schwartz, Michael David & Daniel Mimouni. (2012) Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases. Immunology and Allergy Clinics of North America 32:2, pages 309-315.
Crossref
Clara De Simone, Giacomo Caldarola, Francesca Perino, Antonio Venier & Giuseppe Guerriero. (2012) Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study. Dermatologic Therapy 25:2, pages 219-222.
Crossref
Marina Eskin-Schwartz, Michael David & Daniel Mimouni. (2011) Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases. Dermatologic Clinics 29:4, pages 555-559.
Crossref
C. Le Roux-Villet & C. Prost-Squarcioni. (2011) L’épidermolyse bulleuse acquise : revue de la littérature. Annales de Dermatologie et de Vénéréologie 138:3, pages 228-246.
Crossref
Maria Rita Bongiorno, Giuseppe Pistone, Spyridoula Doukaki & Mario Aricò. (2010) Enteric-coated mycophenolate sodium in the treatment of refractory pemphigus. International Journal of Dermatology 49:6, pages 693-699.
Crossref
A. Lo Schiavo, Rosa Valentina Puca, Vincenzo Ruocco & Eleonora Ruocco. (2010) Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies. Clinics in Dermatology 28:3, pages 337-343.
Crossref
F. Wojnarowska & V. A. Venning. 2010. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology 1 62 .
E Bulbul Baskan, M Yilmaz, S Tunali & H Saricaoglu. (2009) Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris. Journal of the European Academy of Dermatology and Venereology 23:12, pages 1432-1434.
Crossref
Julia S. Lehman, Michael J. Camilleri & Lawrence E. Gibson. (2009) Epidermolysis bullosa acquisita: concise review and practical considerations. International Journal of Dermatology 48:3, pages 227-236.
Crossref
M. Saha, M.M. Black & R.W. Groves. (2008) Risk of herpes zoster infection in patients with pemphigus on mycophenolate mofetil. British Journal of Dermatology.
Crossref
. (2008) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 15:3, pages 284-314.
Crossref
M. Wosnitza, C. Blazek & M. Megahed. (2008) Pemphigus herpetiformisPemphigus herpetiformis. Der Hautarzt 59:6, pages 459-460.
Crossref
Samih Elchahal, Eric R. Kavosh & David S. Chu. (2008) Ocular Manifestations of Blistering Diseases. Immunology and Allergy Clinics of North America 28:1, pages 119-136.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.